• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

转录因子 FOXP3:TFPI 基因的抑制剂?

Transcription factor FOXP3: A repressor of the TFPI gene?

机构信息

Department of Haematology, Oslo University Hospital, Oslo, Norway.

Research Institute of Internal Medicine, Oslo University Hospital, Oslo, Norway.

出版信息

J Cell Biochem. 2019 Aug;120(8):12924-12936. doi: 10.1002/jcb.28563. Epub 2019 Mar 12.

DOI:10.1002/jcb.28563
PMID:30861202
Abstract

Single nucleotide polymorphisms (SNPs) may play an important role in the risk of certain diseases. We have previously shown that the -287T/C SNP of the tissue factor pathway inhibitor (TFPI) gene promoter region exerts differential impact on TFPI mRNA expression; the C allele being associated with higher TFPI expression, which in turn is associated with reduced risk of thrombosis. In the present study, we aimed to reveal the underlying molecular mechanisms using human embryonic kidney 293 (HEK293) and Michigan Cancer Foundation-7 (MCF7) cells that both express TFPI. Transfecting the cells with luciferase reporter gene constructs containing the TFPI promoter with either the T or the C allele of -287T/C resulted in increased luciferase activity with the C allele relative to the T allele. Three potential candidate transcription factors for binding to the two -287 alleles were predicted using the ALGGEN PROMO software, and results from electrophoretic mobility shift assays indicated that forkhead box protein 3 (FOXP3), initially identified as a functional marker of T regulator cells, bound more specifically to the T allele compared with the C allele. By chromatin immunoprecipitation assays analysis it was confirmed that FOXP3 was able to bind to the DNA region that contains the SNP. Knockdown or overexpression of FOXP3 resulted in increased or decreased TFPI levels, respectively, in both cell types. In conclusion, this study indicates that FOXP3 most likely is involved in the increased levels of TFPI observed with the -287C allele and also that FOXP3 might be a repressor for TFPI expression.

摘要

单核苷酸多态性(SNPs)可能在某些疾病的风险中发挥重要作用。我们之前已经表明,组织因子途径抑制剂(TFPI)基因启动子区域的-287T/C SNP 对 TFPI mRNA 表达产生不同的影响;C 等位基因与更高的 TFPI 表达相关,而 TFPI 表达降低又与血栓形成的风险降低相关。在本研究中,我们旨在使用表达 TFPI 的人胚肾 293(HEK293)和密歇根癌症基金会-7(MCF7)细胞揭示潜在的分子机制。用含有 TFPI 启动子的荧光素酶报告基因构建体转染细胞,该启动子具有-287T/C 的 T 或 C 等位基因,导致 C 等位基因相对于 T 等位基因的荧光素酶活性增加。使用 ALGGEN PROMO 软件预测了三个可能与两个-287 等位基因结合的潜在候选转录因子,电泳迁移率变动分析的结果表明,叉头框蛋白 3(FOXP3)最初被鉴定为 T 调节细胞的功能标志物,与 C 等位基因相比,与 T 等位基因的结合更特异。通过染色质免疫沉淀分析证实 FOXP3 能够与包含 SNP 的 DNA 区域结合。在两种细胞类型中,FOXP3 的敲低或过表达分别导致 TFPI 水平增加或减少。总之,本研究表明,FOXP3 很可能参与了与-287C 等位基因相关的 TFPI 水平升高,并且 FOXP3 可能是 TFPI 表达的抑制剂。

相似文献

1
Transcription factor FOXP3: A repressor of the TFPI gene?转录因子 FOXP3:TFPI 基因的抑制剂?
J Cell Biochem. 2019 Aug;120(8):12924-12936. doi: 10.1002/jcb.28563. Epub 2019 Mar 12.
2
Analysis of a T-287C polymorphism in the tissue factor pathway inhibitor gene and identification of a repressor element in the promoter.组织因子途径抑制物基因中T-287C多态性分析及启动子中一个阻遏元件的鉴定。
Thromb Res. 2008;121(6):813-9. doi: 10.1016/j.thromres.2007.08.012. Epub 2007 Oct 10.
3
Functional characterization of polymorphisms in the human TFPI gene.鉴定人组织因子途径抑制物(TFPI)基因多态性的功能特征。
Biochem Biophys Res Commun. 2010 Jun 18;397(1):106-11. doi: 10.1016/j.bbrc.2010.05.078. Epub 2010 May 16.
4
A new T-287C polymorphism in the 5' regulatory region of the tissue factor pathway inhibitor gene. Association study of the T-287C and C-399T polymorphisms with coronary artery disease and plasma TFPI levels.
Thromb Haemost. 2000 Aug;84(2):244-9.
5
[Association of single nucleotide polymorphisms of tissue factor and tissue factor pathway inhibitor with venous thromboembolism in patients with lung cancer].[组织因子和组织因子途径抑制物单核苷酸多态性与肺癌患者静脉血栓栓塞的关联]
Zhonghua Yi Xue Za Zhi. 2018 Mar 27;98(12):901-906. doi: 10.3760/cma.j.issn.0376-2491.2018.12.005.
6
Oestrogens Downregulate Tissue Factor Pathway Inhibitor through Oestrogen Response Elements in the 5'-Flanking Region.雌激素通过 5'-侧翼区域的雌激素反应元件下调组织因子途径抑制剂。
PLoS One. 2016 Mar 21;11(3):e0152114. doi: 10.1371/journal.pone.0152114. eCollection 2016.
7
Tissue factor pathway inhibitor polymorphisms in women with and without a history of venous thrombosis and the effects of postmenopausal hormone therapy.有和无静脉血栓形成病史的女性组织因子途径抑制剂多态性及绝经后激素治疗的影响
Blood Coagul Fibrinolysis. 2010 Sep;21(6):516-21. doi: 10.1097/MBC.0b013e32833a06cd.
8
Tumor expression, plasma levels and genetic polymorphisms of the coagulation inhibitor TFPI are associated with clinicopathological parameters and survival in breast cancer, in contrast to the coagulation initiator TF.与凝血启动因子组织因子(TF)相反,凝血抑制剂组织因子途径抑制物(TFPI)的肿瘤表达、血浆水平及基因多态性与乳腺癌的临床病理参数及生存情况相关。
Breast Cancer Res. 2015 Mar 26;17(1):44. doi: 10.1186/s13058-015-0548-5.
9
ADTRP regulates TFPI expression via transcription factor POU1F1 involved in coronary artery disease.ADTRP 通过参与冠心病的转录因子 POUSF1 调节 TFPI 的表达。
Gene. 2020 Aug 30;753:144805. doi: 10.1016/j.gene.2020.144805. Epub 2020 May 20.
10
Polymorphisms of the tissue factor pathway inhibitor gene are associated with venous thromboembolism in the antiphospholipid syndrome and carriers of factor V Leiden.组织因子途径抑制物基因多态性与抗磷脂综合征及凝血因子V Leiden携带者的静脉血栓栓塞相关。
Blood Coagul Fibrinolysis. 2007 Sep;18(6):559-64. doi: 10.1097/MBC.0b013e3281eec977.

引用本文的文献

1
Functionally Antagonistic Transcription Factors IRF1 and IRF2 Regulate the Transcription of the Dopamine Receptor D2 Gene Associated with Aggressive Behavior of Weaned Pigs.功能拮抗转录因子IRF1和IRF2调节与断奶仔猪攻击行为相关的多巴胺受体D2基因的转录。
Biology (Basel). 2022 Jan 14;11(1):135. doi: 10.3390/biology11010135.
2
Knockdown screening of chromatin binding and regulatory proteins in zebrafish identified Suz12b as a regulator of tfpia and an antithrombotic drug target.在斑马鱼中对染色质结合和调节蛋白进行的敲低筛选鉴定 Suz12b 为 tfpia 的调节剂和抗血栓药物靶点。
Sci Rep. 2021 Jul 27;11(1):15238. doi: 10.1038/s41598-021-94715-2.
3
Indirect regulation of TFPI-2 expression by miR-494 in breast cancer cells.
miR-494 对乳腺癌细胞 TFPI-2 表达的间接调控。
Sci Rep. 2020 Mar 4;10(1):4036. doi: 10.1038/s41598-020-61018-x.